These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 10629359

  • 21. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele.
    Soininen H, Kosunen O, Helisalmi S, Mannermaa A, Paljärvi L, Talasniemi S, Ryynänen M, Riekkinen P.
    Neurosci Lett; 1995 Mar 03; 187(2):79-82. PubMed ID: 7783963
    [Abstract] [Full Text] [Related]

  • 22. Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia.
    Rodriguez Martin T, Calella AM, Silva S, Munna E, Modena P, Chiesa R, Terrevazzi S, Ruggieri RM, Palermo R, Piccoli F, Confalonieri R, Tiraboschi P, Fragiacomo C, Quadri P, Lucca U, Forloni G.
    Dement Geriatr Cogn Disord; 2000 Mar 03; 11(5):239-44. PubMed ID: 10940674
    [Abstract] [Full Text] [Related]

  • 23. Contribution of apolipoprotein E and cathepsin D genotypes to the familial aggregation of Alzheimer's disease.
    Heun R, Ptok U, Kölsch H, Maier W, Jessen F.
    Dement Geriatr Cogn Disord; 2004 Mar 03; 18(2):151-8. PubMed ID: 15211070
    [Abstract] [Full Text] [Related]

  • 24. Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease.
    Wang PN, Liu HC, Liu TY, Chu A, Hong CJ, Lin KN, Chi CW.
    Dement Geriatr Cogn Disord; 2005 Mar 03; 19(2-3):120-5. PubMed ID: 15591802
    [Abstract] [Full Text] [Related]

  • 25. Distribution of apolipoprotein E4 isoform in Alzheimer's disease in Poland.
    Bratosiewicz-Zapart J, Kłoszewska I, Sobów T, Liberski PP.
    Arch Immunol Ther Exp (Warsz); 1997 Mar 03; 45(2-3):221-2. PubMed ID: 9597090
    [Abstract] [Full Text] [Related]

  • 26. SREBP-1a polymorphism influences the risk of Alzheimer's disease in carriers of the ApoE4 allele.
    Spell C, Kölsch H, Lütjohann D, Kerksiek A, Hentschel F, Damian M, von Bergmann K, Rao ML, Maier W, Heun R.
    Dement Geriatr Cogn Disord; 2004 Mar 03; 18(3-4):245-9. PubMed ID: 15286454
    [Abstract] [Full Text] [Related]

  • 27. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
    Cui T, Zhou X, Jin W, Zheng F, Cao X.
    Chin Med J (Engl); 2000 Apr 03; 113(4):340-4. PubMed ID: 11775232
    [Abstract] [Full Text] [Related]

  • 28. [Apolipoprotein E 4 gene is a risk factor for Alzheimer's disease].
    Peng D, Xu X, Feng Y.
    Zhonghua Nei Ke Za Zhi; 2001 Oct 03; 40(10):688-90. PubMed ID: 11769724
    [Abstract] [Full Text] [Related]

  • 29. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.
    Arch Neurol; 2005 Mar 03; 62(3):454-9. PubMed ID: 15767511
    [Abstract] [Full Text] [Related]

  • 30. Apolipoprotein E epsilon 4 allele and whole brain atrophy in late-onset Alzheimer's disease.
    Yasuda M, Mori E, Kitagaki H, Yamashita H, Hirono N, Shimada K, Maeda K, Tanaka C.
    Am J Psychiatry; 1998 Jun 03; 155(6):779-84. PubMed ID: 9619150
    [Abstract] [Full Text] [Related]

  • 31. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, Caimi L, Caltagirone C, Di Luca M, Padovani A, ITINAD Working Group.
    Neurobiol Aging; 2009 Sep 03; 30(9):1406-12. PubMed ID: 18179845
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype.
    Bronge L, Fernaeus SE, Blomberg M, Ingelson M, Lannfelt L, Isberg B, Wahlund LO.
    Dement Geriatr Cogn Disord; 1999 Sep 03; 10(2):89-96. PubMed ID: 10026381
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population.
    Schwab SG, Bagli M, Papassotiropoulos A, Jessen F, Maier W, Rao ML, Heun R.
    Dement Geriatr Cogn Disord; 1999 Sep 03; 10(6):469-72. PubMed ID: 10559561
    [Abstract] [Full Text] [Related]

  • 37. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease.
    Beyer K, Lao JI, Latorre P, Ariza A.
    Ann N Y Acad Sci; 2005 Dec 03; 1057():260-78. PubMed ID: 16399900
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.
    D'Onofrio G, Panza F, Seripa D, Sancarlo D, Paris F, Cascavilla L, Urbano M, Gravina C, Fontana A, Solfrizzi V, Pellegrini F, Pilotto A.
    Int J Geriatr Psychiatry; 2011 Oct 03; 26(10):1062-70. PubMed ID: 21905100
    [Abstract] [Full Text] [Related]

  • 40. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
    Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT.
    Ann Neurol; 1996 Jan 03; 39(1):62-70. PubMed ID: 8572669
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.